Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (112)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sharp, J. D.
Right arrow Articles by Williams, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharp, J. D.
Right arrow Articles by Williams, R. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 6, 591-595, Copyright © 1997 by Oxford University Press


ARTICLES

Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23

JD Sharp, RB Wheeler, BD Lake, M Savukoski, IE Jarvela, L Peltonen, RM Gardiner and RE Williams
Department of Paediatrics, University College London Medical School, The Rayne Institute, UK.

The childhood neuronal ceroid lipofuscinoses (NCLs) are a group of autosomal recessive neurodegenerative disorders characterised by progressive visual failure, neurodegeneration, epilepsy and the accumulation of an autofluorescent lipopigment in neurones and other cells. Three main subtypes have been identified according to age of onset, clinical features and ultrastructural morphology. These are infantile NCL (INCL; CLN1), classical late infantile NCL (LINCL; CLN2) and juvenile NCL (JNCL; CLN3). Several atypical forms of late infantile NCL (LINCL) have also been described including a Finnish variant LINCL (CLN5). The CLN2 gene has been excluded from the CLN1, CLN3 and CLN5 loci. A genome search was initiated using a homozygosity mapping strategy in five classical LINCL and two variant LINCL consanguineous families. A common region of homozygosity was identified on chromosome 11p15 in two of the classical families. Analysis of a further 33 classical LINCL families supported linkage in this region (Zmax = 3.07 at theta = 0.06 at D11S1338). A common region of homozygosity was also observed on chromosome 15q21-23 in the two variant LINCL families. Extension of the analysis to include a further seven families of identical ultrastructural phenotype established linkage to this region (Zmax = 6.00 at theta = 0.00 at D15S1020).
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
M. Kousi, E. Siintola, L. Dvorakova, H. Vlaskova, J. Turnbull, M. Topcu, D. Yuksel, S. Gokben, B. A. Minassian, M. Elleder, et al.
Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis
Brain, March 1, 2009; 132(3): 810 - 819.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. E. Sleat, J. A. Wiseman, M. El-Banna, K.-H. Kim, Q. Mao, S. Price, S. L. Macauley, R. L. Sidman, M. M. Shen, Q. Zhao, et al.
A Mouse Model of Classical Late-Infantile Neuronal Ceroid Lipofuscinosis Based on Targeted Disruption of the CLN2 Gene Results in a Loss of Tripeptidyl-Peptidase I Activity and Progressive Neurodegeneration
J. Neurosci., October 13, 2004; 24(41): 9117 - 9126.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. A. Golabek, E. Kida, M. Walus, P. Wujek, P. Mehta, and K. E. Wisniewski
Biosynthesis, Glycosylation, and Enzymatic Processing in Vivo of Human Tripeptidyl-peptidase I
J. Biol. Chem., February 21, 2003; 278(9): 7135 - 7145.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
W Ju, R Zhong, S Moore, D Moroziewicz, J R Currie, P Parfrey, W T Brown, and N Zhong
Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles
J. Med. Genet., November 1, 2002; 39(11): 822 - 825.
[Full Text] [PDF]


Home page
NEJMHome page
R. S. Rust and D. Karluk
Case 27-2002 - A 5 1/2-Year-Old Boy with Seizures and Progressive Deterioration of Cognitive and Motor Function
N. Engl. J. Med., August 29, 2002; 347(9): 672 - 680.
[Full Text] [PDF]


Home page
NeurologyHome page
K. E. Wisniewski, N. Zhong, and M. Philippart
Pheno/genotypic correlations of neuronal ceroid lipofuscinoses
Neurology, August 28, 2001; 57(4): 576 - 581.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R. Robinson and M. Gardiner
Current topic: Genetics of childhood epilepsy
Arch. Dis. Child., February 1, 2000; 82(2): 121 - 125.
[Full Text]


Home page
J. Neurosci.Home page
J. D. Cooper, A. Messer, A. K. Feng, J. Chua-Couzens, and W. C. Mobley
Apparent Loss and Hypertrophy of Interneurons in a Mouse Model of Neuronal Ceroid Lipofuscinosis: Evidence for Partial Response to Insulin-Like Growth Factor-1 Treatment
J. Neurosci., April 1, 1999; 19(7): 2556 - 2567.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. A. Soyombo and S. L. Hofmann
Molecular Cloning and Expression of Palmitoyl-protein Thioesterase 2 (PPT2), a Homolog of Lysosomal Palmitoyl-protein Thioesterase with a Distinct Substrate Specificity
J. Biol. Chem., October 24, 1997; 272(43): 27456 - 27463.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. E. Sleat, R. J. Donnelly, H. Lackland, C. Liu, I. Sohar, R. K. Pullarkat, and P. Lobel
Association of Mutations in a Lysosomal Protein with Classical Late-Infantile Neuronal Ceroid Lipofuscinosis
Science, September 19, 1997; 277(5333): 1802 - 1805.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.